Why Indian Drugmakers Are In More Pain

Why are investors moving away from generic pharma companies to pharma ancillaries and MNC stocks.

--------------------------------------------------------------------------------------------------------------------
For more videos subscribe to our channel:
Visit BloombergQuint for more news:

For the latest business news and analysis
Subscribe to #BQBlue:
Subscribe to our Daily Newsletter here:
Subscribe to our Telegram channel:

Follow BloombergQuint here
Twitter:
Facebook:
LinkedIn:

Bloomberg,BloombergQuint,Business,India,News,drugmakers,MNC stocks,pharma,